Top

Journal of Translational Medicine

Published in:

Open Access 01-12-2013 | Research

Invasive colon cancer, but not non-invasive adenomas induce a gradient effect of Wnt pathway receptor frizzled 1 (Fz1) expression in the tumor microenvironment

Authors: Kestutis Planutis, Marina Planutiene, Anthony V Nguyen, Mary Pat Moyer, Randall F Holcombe

Published in: Journal of Translational Medicine | Issue 1/2013

Abstract

Background

Wnt signaling in the colon cancer tumor microenvironment (TME) may affect cancer biologic properties including invasion and metastatic dissemination. Prior reports have suggested that the expression of select frizzled (Fz) receptors may be altered in cancers and in the TME.

Methods

Colon cancer, colonic adenoma and normal colonic mucosal specimens were obtained under institutional review board approval and analyzed for the expression of Fz1 and Fz2 by confocal fluorescent immunohistochemistry and Wnt-specific membrane array. In vitro, the effect of Wnt3a on Fz1 expression was examined in normal-derived NCM460 cells by qRT-PCR and immunohistochemistry.

Results

Fz1 was expressed in colon cancer and villous adenomas but not in more benign tubular adenomas. Fz1 expression was seen in normal colonic mucosa in close proximity to colon cancer, but not villous or tubular adenomas. Normal colonic mucosa distant from colon cancer did not express Fz1. Fz2 was expressed ubiquitously in cancer, adenomas and normal colonic mucosa. Fz1 expression was induced by Wnt3a in a normal colon mucosa-derived cell line in vitro.

Conclusions

Fz1 is a Wnt responsive gene in colon-derived tissues. Fz1 expression exhibited increased expression in normal mucosa only in close proximity to colon cancer. This field effect was not seen with pre-malignant adenomas and may be due to Wnt/β-catenin signaling within the TME. Fz1 may represent a new TME-directed therapeutic target for patients with colon cancer.

Available only for authorised users

Witz IP: Yin-yang activities and vicious cycles in the tumor microenvironment. Cancer Res. 2008, 68: 9-13. 10.1158/0008-5472.CAN-07-2917.CrossRefPubMed

Miyaki M, Konishi M, Kikuchi-Yanoshita R, Enomoto M, Igari T, Tanaka K, Muraoka M, Takahashi H, Amada Y, Fukayama M, Maeda Y, Iwama T, Mishima Y, Mori T, Koike M: Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res. 1994, 54: 3011-3020.PubMed

Naji R, Holcombe RF, Waterman ML: Wnt signaling and colon carcinogenesis: Beyond APC. J Carcinogenesis. 2011, 10: 5-13. 10.4103/1477-3163.78111.CrossRef

Lau W, Barker N, Clevers H: Wnt signaling in the normal intestine and colorectal cancer. Front Biosci. 2007, 12: 471-491. 10.2741/2076.CrossRefPubMed

Vermeulen L, DeSousa EMF, van der Heijden M, Cameron K, de Jong JH, Borovski R, Tuynman JB, Todaro M, Merz C, Rodermond H, Sprick MR, Kemper K, Richel DJ, Stassi G, Medema JP: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Bio. 2010, 12: 468-476. 10.1038/ncb2048.CrossRef

Le NH, Franken P, Fodde R: Tumour-stroma interactions in colorectal cancer: converging on beta-catenin activation and cancer stemness. Br J Cancer. 2008, 98: 1886-1893. 10.1038/sj.bjc.6604401.PubMedCentralCrossRefPubMed

Bandapalli OR, Dihlmann S, Helwa R, Macher-Geoppinger S, Weitz J, Schirmacher P, Brand K: Transcriptional activation of the beta-catenin gene at the invasion front of colorectal liver metastases. J Pathol. 2009, 218: 370-379. 10.1002/path.2539.CrossRefPubMed

Bafico A, Liu G, Goldin L, Harris V, Aaronson SA: An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell. 2004, 6: 497-506. 10.1016/j.ccr.2004.09.032.CrossRefPubMed

Holcombe RF, Marsh JL, Waterman ML, Milovanovic T, Truong T: Expression of Wnt ligands and frizzled receptors in colonic mucosa and in colon carcinoma. Mol Pathol. 2002, 55: 220-226. 10.1136/mp.55.4.220.PubMedCentralCrossRefPubMed

10.

Jung A, Schrauder M, Oswald U, Knoll C, Sellberg P, Palmqvist R, Niedobitek G, Brabletz T, Kirchner T: The Invasion Front of Human Colorectal Adenocarcinomas Shows Co-Localization of Nuclear β-Catenin, Cyclin D1, and p16INK4A and Is a Region of Low Proliferation. Am J Pathol. 2001, 159: 1613-1617. 10.1016/S0002-9440(10)63007-6.PubMedCentralCrossRefPubMed

11.

Macheda ML, Stacker SA: Importance of Wnt signaling in the tumor stroma microenvironment. Curr Cancer Drug Targets. 2008, 8: 454-465. 10.2174/156800908785699324.CrossRefPubMed

12.

Van Amerongen R, Nusse R: Toward an integrated view of Wnt signaling in development. Development. 2009, 36: 3205-3214.CrossRef

13.

Vincan E, Flanagan DJ, Pouliot N, BRabletz R, Spaderna S: Variable FZD7 expression in colorectal cancers indicates regulation by the tumor microenvironment. Dev Dyn. 2010, 239: 311-317.PubMed

14.

Ueno K, Hazama S, Mitormori S, Nishioka M, Suehiro Y, Hirata H, Oka M, Imai K, Dahiya R, Hinoda Y: Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells. Br J Cancer. 2009, 101: 1374-1381. 10.1038/sj.bjc.6605307.PubMedCentralCrossRefPubMed

15.

Nguyen AV, Albers CG, Holcombe RF: Differentiation of tubular and villous adenomas based on Wnt pathway-related gene expression profiles. Int J Mol Med. 2010, 26: 121-5.PubMed

16.

Moyer MP, Stauffer JS, Manzano LA, Tanzer LR, Merriman RL: NCM460, A normal human colon mucosal epithelial cell Line. In Vitro Cell Dev Biol Anim. 1996, 32: 315-317. 10.1007/BF02722955.CrossRefPubMed

17.

Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya T, Yates JR, Nusse R: Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature. 2003, 423: 448-452. 10.1038/nature01611.CrossRefPubMed

18.

Milovanovic T, Planutis K, Nguyen A, Marsh L, Lin F, Hope C, Holcombe RF: Expression of Wnt genes and frizzled 1 and 2 receptors in normal breast epithelium and infiltrating breast carcinoma. Int J Oncol. 2004, 25: 1337-1342.PubMed

19.

Flahaut M, Meier R, Coulon A, Nardou KA, Niggli FK, Martinet D, Bechmann JS, Joseph JM, Muehlethaler-Mottet A, Gross N: The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway. Oncogene. 2009, 28: 2245-2256. 10.1038/onc.2009.80.CrossRefPubMed

20.

Neumann J, Schaale K, Farhat K, Endermann T, Ulmer AJ, Ehlers S, Reiling N: Frizzled 1 is a marker of inflammatory macrophages and its ligand Wnt3a is involved in reprogramming Mycobacterium tuberculosis-infected macrophages. FASEB J. 2010, 24: 4599-4612. 10.1096/fj.10-160994.CrossRefPubMed

21.

Chacon MA, Varela-Nallar L, Inestrosa NC: Frizzled-1 is involved in the neuroprotective effect of Wnt3a against Abeta oligomers. J Cell Physiol. 2008, 217: 215-227. 10.1002/jcp.21497.CrossRefPubMed

22.

Roman-Roman S, Shi E-L, Stiot V, Hay E, Vayssiere B, Garcia R, Baron R, Rawadi G: Murine frizzled-1 behaves as an antogaonist of the canonical Wnt/β-catinin signaling. J Biol Chem. 2004, 279: 5725-5733.CrossRefPubMed

23.

Sato A, Yamamoto H, Sakane H, Koyama H, Kikuchi A: Wnt5a regulates distinct signaling pathways by binding to frizzled 2. EMBO J. 2010, 29: 41-54. 10.1038/emboj.2009.322.PubMedCentralCrossRefPubMed

24.

Brabletz T, Jung A, Hermann K, Guenther K, Hohenberger W, Kirchner T: Nuclear overexpression of the oncoprotein β-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract. 1998, 194: 701-704. 10.1016/S0344-0338(98)80129-5.CrossRefPubMed

25.

Suzuki H, Watkins DN, Jair K-W, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, van Engeland M, Toyota M, Tokino T, Hinoda Y, Imai K, Herman JG, Baylin SB: Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet. 2004, 36: 417-422. 10.1038/ng1330.CrossRefPubMed

26.

Kobayashi M, Honma T, Matsuda Y, Suzuki Y, Narisawa R, Ajioka Y, Asakura H: Nuclear translocation of beta-catenin in colorectal cancer. Br J Cancer. 2000, 82: 1689-1693.PubMedCentralCrossRefPubMed

27.

Kolben T, Perobner I, Fernsebner K, Lechner F, Geissler C, Ruiz-Heinrich L, Capovilla S, Jochum M, Neth P: Dissecting the impact of frizzled receptors in Wnt/β-catenin signaling of human mesenchymal stem cells. Biol Chem. 2012, 393: 1433-1447.CrossRefPubMed

28.

Wels J, Kaplan RN, Rafii S, Lyden D: Migratory neighbors and distant invaders: tumor –associated niche cells. Genes Dev. 2008, 22: 559-574. 10.1101/gad.1636908.PubMedCentralCrossRefPubMed

29.

Lieberman DA, Smith FW: Screening for colon malignancy with colonoscopy. Am J Gastroenterol. 1991, 86: 946-951.PubMed

Title: Invasive colon cancer, but not non-invasive adenomas induce a gradient effect of Wnt pathway receptor frizzled 1 (Fz1) expression in the tumor microenvironment
Authors: Kestutis Planutis
Marina Planutiene
Anthony V Nguyen
Mary Pat Moyer
Randall F Holcombe
Publication date: 01-12-2013
Publisher: BioMed Central
Published in: Journal of Translational Medicine / Issue 1/2013
Electronic ISSN: 1479-5876
DOI: https://doi.org/10.1186/1479-5876-11-50

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2013

Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer

Id1 enhances human ovarian cancer endothelial progenitor cell angiogenesis via PI3K/Akt and NF-κB/MMP-2 signaling pathways

TNF gene polymorphisms in cystic fibrosis patients: contribution to the disease progression

Saturable human neopterin response to interferon-α assessed by a pharmacokinetic-pharmacodynamic model

Detection of colon polyps by a novel, polymer pattern-based full blood test

Variants in toll-like receptor 9 gene influence susceptibility to tuberculosis in a Mexican population

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials